Skip to content
Research Article Open access CC BY 4.0

Estradiol and/or Ibandronate Therapy Ameliorates A Case Series Describing the Outcomes of Treatment in Co-infected Patients with HIV and Hepatitis C on the United States-Mexico Border

Grecia Heredia, Suresh J. Antony

Journal of Advances in Medicine and Medical Research · pp. 1–7 · Published 16 May 2016

10.9734/BJMMR/2016/26229

Abstract

According to the National Health and Nutrition Examination Survey 2007-2010 (NHANES) and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the prevalence of Hepatitis C in people of Hispanic descent is 1.5-2%. However, this percentage is estimated to increase as the Hispanic population continues to grow in the United States. Currently there is minimal information on Hepatitis C treatment outcomes in the Hispanic population and even less data in the HIV co-infected, Hispanic population. This study was done to see if there was any differences in the clinical features and treatment outcomes in a population where the predominant race was that of Hispanics. In this small study, we enrolled 36 patients to evaluate the demographics, efficacy of various direct acting anti-Hepatitis C medications in HIV co-infected patients. All the patients were male with over 94% being of Hispanic origin. The average CD4 count at enrollment was 234 cell/cu mm and at the end of treatment was 256 cells/cu mm. A sustained viral response (SVR) or the definition of cure, was noted in all but one of the patients regardless of the medication used, underlying liver stage, or stage of HIV infection.

HIV hepatitis C treatment outcomes

References (17)

  1. 1 Boceprevir for Untreated Chronic HCV Genotype 1 Infection [DOI]
  2. 2 Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection [DOI]
  3. 3 Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study [DOI]
  4. 4 Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1 [DOI]
  5. 5 Increasing burden of liver disease in patients with HIV infection [DOI]
  6. 6 Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection [DOI]
  7. 7 Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.
  8. 8 Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV [DOI]
  9. 9 Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV [DOI]
  10. 10 Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study [DOI]
  11. 11 Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review [DOI]
  12. 12 Racial Differences in the Progression to Cirrhosis and Hepatocellular Carcinoma in HCV-Infected Veterans [DOI]
  13. 13 Evaluation of Adherence and Factors Affecting Adherence to Combination Antiretroviral Therapy Among White, Hispanic, and Black Men in the MACS Cohort [DOI]
  14. 14 Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations [DOI]
  15. 15 The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1 [DOI]
  16. 16 Impact of Hispanic or Asian Ethnicity on the Treatment Outcomes of Chronic Hepatitis C [DOI]
  17. 17 Influence of Treatment Complexity on Adherence and Incidence of Blips in HIV/HCV Coinfected Patients [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

36

Page views

0

PDF downloads

7

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.